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Introduction: Hyperchloremic acidosis is frequent in critically ill patients. Renal tubular acidosis (RTA) may contribute
to acidemia in the state of hyperchloremic acidosis, but the prevalence of RTA has never been studied in critically ill
patients. Therefore, we aimed to investigate the prevalence, type, and possible risk factors of RTA in critically ill patients
using a physical-chemical approach.
Methods: This prospective, observational trial was conducted in a medical ICU of a university hospital. One hundred
consecutive critically ill patients at the age ≥18, expected to stay in the ICU for ≥24 h, with the clinical necessity for a
urinary catheter and the absence of anuria were included.
Base excess (BE) subset calculation based on a physical-chemical approach on the first 7 days after ICU admission was
used to compare the effects of free water, chloride, albumin, and unmeasured anions on the standard base excess.
Calculation of the urine osmolal gap (UOG) - as an approximate measure of the unmeasured urine cation NH4
+ - served
as determinate between renal and extrarenal bicarbonate loss in the state of hyperchloremic acidosis.
Results: During the first week of ICU stay 43 of the patients presented with hyperchloremic acidosis on one or more
days represented as pronounced negative BEChloride. In 31 patients hyperchloremic acidosis was associated with RTA
characterized by a UOG ≤150 mosmol/kg in combination with preserved renal function. However, in 26 of the 31
patients with RTA metabolic acidosis was neutralized by other acid-base disturbances leading to a normal arterial pH.
Conclusions: RTA is highly prevalent in critically ill patients with hyperchloremic acidosis, whereas it is often
neutralized by the simultaneous occurrence of other acid-base disturbances.
Trial registration: Clinicaltrials.gov NCT02392091. Registered 17 March 2015Introduction
Imbalances of the acid-base state and particularly meta-
bolic acidosis are common problems in critically ill pa-
tients. To further investigate the underlying causes,
analysis of the acid-base state and determination of
plasma and urine electrolytes are crucial [1]. Metabolic
acidosis is subdivided in conditions with either high
serum anion gap (SAG) or normal SAG according to the
classic model of metabolic acid-base disorders. The SAG
is the difference in the measured cations (Na+, K+) and
anions (Cl−, HCO3−) in serum.
High SAG is typical for the occurrence of unmeasured
anions (for example ketones, lactate, metabolites of* Correspondence: bruno.schneeweiss@gespag.at
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unless otherwise stated.methanol and ethylene glycol, phosphate) where HCO3−
is consumed via its action as a buffer. High SAG meta-
bolic acidosis is seen in ketoacidosis, lactic acidosis,
intoxication and acute renal failure [2].
Metabolic acidosis with normal SAG - hyperchloremic
acidosis - is characterized by the replacement of bicar-
bonate with chloride caused by extrarenal or renal bicar-
bonate disposal or a dysfunction in renal H+ secretion
[1]. Hyperchloremic acidosis is typically seen in bicar-
bonate wasting due to diarrhea, urine-gut diversions, in-
testinal or pancreatic fistulae, surgical drains or renal
tubular acidosis (RTA) [3].
The analysis of the urine osmolal gap (UOG) is neces-
sary to further differentiate these conditions. The UOG
represents the difference of the directly measured urine
osmolality to an estimate of the urine osmolality derivedl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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urea nitrogen, and glucose concentrations [4].
A UOG - as an approximate measure of unmeasured
urine ammonium salts - of less than 150 mosmol/kg in
combination with a preserved renal function [5] is char-
acteristic for altered urine acidification typical for RTA
[4,6], while a UOG of more than 150 mosmol/kg sug-
gests extrarenal bicarbonate loss.
The UOG, in contrast to the urine anion gap, is not
invalidated by increased excretion of unmeasured anions
and therefore is the preferred measure to further analyze
the causes for hyperchloremic acidosis in critically ill pa-
tients [7,8].
Type 1 (distal) RTA is based on defective distal tubular
H+ secretion and is characterized by inadequately high
urinary pH (>5.3) during hyperchloremic metabolic acid-
osis. In type II (proximal) RTA the underlying cause is a
defect in proximal tubule bicarbonate reabsorption. This
results in urinary bicarbonate loss also resulting in in-
appropriately high urine pH during hyperchloremic acid-
osis. However, in established type II RTA, after severe
bicarbonate depletion has occurred, minimum urinary pH
is usually below pH 5.3. Type IV RTA is based on min-
eralocorticoid deficiency or inadequate renal response to
mineralocorticoids. It is characterized by low urinary pH
and - contrary to RTA types I/II - hyperkalemia [3,9].
The prevalence of RTA and underlying metabolic
changes has been studied in patients after kidney trans-
plantation [9] and in osteoporotic patients [10]. How-
ever, studies in critically ill patients are lacking.
Based on the physical-chemical approach, more than
one metabolic acid-base disorder at the same time was
found to be common in critical illness [11]. Thus, ‘meta-
bolic acidosis’ and ‘metabolic alkalosis’ may be present
in the same patient at the same time, potentially leading
to normal pH values. The terms ‘acidosis’ and ‘alkalosis’
are defined as separate effects that decrease or increase
arterial pH, respectively, whereas ‘acidemia’ and ‘alkale-
mia’ are defined as net arterial pH <7.35 or >7.45,
respectively.
Therefore, the aim of this study was to determine the
prevalence of RTA in critically ill patients and to analyze
the underlying acid-base state using a physical-chemical
approach according to Gilfix et al. [12].
Materials and methods
Patients and setting
This prospective, observational trial was conducted in an
eight-bed medical ICU at the University Hospital of
Vienna, Austria between April and October 2011. One
hundred consecutive critically ill patients fulfilling the
inclusion criteria (age ≥18, the expectancy to stay in the
ICU for ≥24 h, and the clinical necessity for a urinary
catheter) were enrolled within 36 hours after ICUadmission. Patients expected to stay <24 h and anuric
patients were excluded from enrollment.
Data of routinely obtained blood from arterial blood
lines and urine samples were collected in all patients up
to 7 days after study inclusion. Arterial blood gas ana-
lysis (pH, sodium, chloride, potassium, standard bicar-
bonate, standard base excess (SBE), pCO2, and lactate)
was performed daily at 05:00 a.m. using a blood gas
analyzer (ABL 725, Radiometer, Copenhagen, Denmark).
At the same time, arterial plasma concentrations of albu-
min, creatinine, blood urea nitrogen, hemoglobin, phos-
phate, and magnesium, as well as spot urine concentrations
of sodium, potassium, chloride, osmolality, and urine pH
were measured at the hospital’s routine laboratory using a
fully automated analyzer (Hitachi 917, Roche Diagnostics
GmbH, Mannheim, Germany). Spot urine was obtained
by clamping the patient’s urine catheter for one hour. Sub-
sequently, a urine sample was obtained for analysis as de-
scribed above.
For every patient the following data were routinely
documented: age, sex, height, weight, body mass index,
admission reason and comorbidities, medication, Acute
Physiology and Chronic Evaluation II (APACHE II)
score, Simplified Acute Physiology Score II (SAPS II)
score, Sequential Organ Failure Assessment (SOFA)
score and body temperature. Heart rate, blood pressure,
and urinary output were routinely documented every
4 hours and creatinine clearance was calculated every
24 hours.
The study was approved by the Ethics Committee of the
Medical University of Vienna. According to the Austrian
law and the guidelines of the research ethics committee,
written informed consent was obtained from patients after
they regained consciousness.
Acid-base analysis and calculation of urine osmolal gap
The acid-base state was analyzed using a physical-
chemical approach [12]. The SBE is influenced by alter-
ations of free water, chloride, albumin, and unmeasured
anions. Therefore, SBE is composed of four subsets
which were calculated as follows [11].
Base excess (BE) caused by the free water effect:
Base excessSodium ¼ 0:3  Naþmeasured − Naþnormalð Þ
The acid-base state is altered by chloride. This effect
can be obtained by first correcting for changes in free
water:
Cl−Naþcorrected ¼ Cl−  Naþnormal=Naþmeasuredð Þð Þ
Base excess changes based on changes in chloride:
Base excessChloride ¼ Cl−normal – Cl−Naþcorrected
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effect due to albumin was calculated as:Base excessAlbumin ¼ 0:148 pHarterial − 0:818ð Þ
 Albuminnormal − Albuminmeasuredð Þ:
Cl−normal ¼ 105 mg=dL; Naþnormal ¼ 140 mg=dL;
Albuminnormal ¼ 42 g=L
Further changes in base excess are based on alterations
of unmeasured anions like lactate or ketone bodies.
Their effect on the base excess was quantified as follows:
Base excessunmeasured anions
¼ Base excess – ðBase ExcessSodium þ Base ExcessChloride
þ Base ExcessAlbuminÞ
Based on these calculations hyperchloremic acidosis
was defined as: base excess attributable to changes of
plasma chloride (BEChloride) ≤ −5 mmol/L. Hyperchlore-
mic acidosis is characterized by extrarenal or renal bicar-
bonate disposal or a dysfunction in renal H+ secretion.
To further investigate the primary cause of hyperchlore-
mic acidosis the UOG was calculated.
The UOG represents the difference of the directly
measured urine osmolality to an estimate of the urine
osmolality derived from the urine concentrations of so-
dium, potassium, urea nitrogen, and glucose concentra-
tions using the following formula [4]: calculated urine
osmolality (mosmol/kg) = (2 × (Na+ + K+)) + (urea nitrogen
in mg/dL)/2.8 + (glucose in mg/dL)/18.
The UOG is an approximate measure of unmeasured
urine ammonium salts, which generally are the only
other major urinary solutes that contribute significantly
to the urine osmolality.
The major renal response to metabolic acidosis is in-
creased NH4+ excretion. Therefore, a UOG of less than
150 mosmol/kg in combination with a preserved renal
function (glomerular filtration rate >25 ml/min [5]) repre-
sents an inadequate renal response and is characteristic
for RTA [4,6], while a UOG of more than 150 mosmol/kg
suggests extrarenal bicarbonate loss.
Subtypes of RTA were determined as follows [3,9]:
RTA type I (distal): hyperchloremic acidosis with a
minimum urine pH ≥5.3 and low/normal plasma potas-
sium (<5.5 mmol/L), based on reduced H+ secretion in
the distal tubule.
RTA type II (proximal): hyperchloremic acidosis with a
minimum urine pH <5.3 and low/normal plasma potas-
sium (<5.5 mmol/L), based on reduced HCO3− reabsorp-
tion in the proximal tubule.
RTA type IV: hyperchloremic acidosis with a minimum
urine pH <5.3 and high plasma potassium (≥5.5 mmol/L),
based on reduced H+ and K+ excretion in the distal
tubule.Transient RTA was defined as RTA on a single study
day, while persistent RTA was defined as RTA on two or
more days.
Objectives
The primary objective was to evaluate the prevalence of
RTA in critically ill patients during the first week after
intensive care unit (ICU) admission, defined as hyper-
chloremic acidosis (BEChloride) ≤ −5 mmol/L), a UOG of
less than 150 mosmol/kg, and a preserved renal func-
tion. Secondary outcome measures were to evaluate the
risk factors for RTA.
Statistics
Data are presented as mean ± standard deviation, median
(25th to 75th percentile) or absolute count and relative
frequency. For bivariate comparisons, we tabulated data
and used t test, Mann-Whitney U test, chi-squared or
Fisher's exact test as appropriate to test the null hypoth-
esis of no difference.
To assess the predictive value of potential risk factors
on the incidence of RTA we performed a binary logistic
regression analysis with RTA as outcome and diabetes,
hypertension, congestive heart failure, chronic kidney
disease, liver cirrhosis, neuroleptic drugs, muscle relax-
ants, combined antibiotic schemes, plasmapheresis, and
sedoanalgesia, as well as age, body mass index (BMI),
gender, and severity of illness (SAPS II) as co-factors.
To assess the effect of transient versus persistent RTA
we conducted four multivariate regression analyses with
the outcomes ‘length of ICU stay’, ‘length of hospital
stay’, ‘ICU survival’ or ‘hospital survival’ and the co-
factors RTA (persistent vs. transient) and ‘number of
study days’.
For data management and statistical analyses we used
Microsoft Excel 2010 and IBM SPSS (version 20) for
Windows (IBM Corp, Armonk, NY, USA).
Results
In this prospective, observational trial we included 100
critically ill patients (Table 1), which were evaluated daily
for hyperchloremic acidosis and RTA during the first week
after ICU admission. In total, 373 complete data sets -
each representing one patient day - derived from arterial
blood and spot urine samples were analyzed.
During the first week of ICU stay 43 of the patients pre-
sented with hyperchloremic acidosis on one or more days
represented as pronounced negative BEChloride (Figure 1).
In 31 patients hyperchloremic acidosis was associated with
RTA characterized by a UOG of less than 150 mosmol/kg
and a preserved renal function. The majority (23 of 31) of
patients with RTA presented with RTA type II, while 8 of
31 patients showed characteristics of RTA type I. How-
ever, in 26 of the 31 patients with RTA, metabolic acidosis
Table 1 Admission reason and patients’ characteristics
Admission reason N = 100
Respiratory failure 31











Chronic renal failure 18
Liver cirrhosis 11
Congestive heart failure 45
Acute or acute-on-chronic renal failure 13
Nephrotoxic medication during study period 93
Amphotericin B 4
Neuroleptic drugs 13





Shock during study period 57
Sepsis during study period 42
Mechanical ventilation during study period 73
Age (years) 62 ± 16
Gender (female/male) 40/60
BMI (kg/m2) 26 ± 5
SOFA score 8 ± 4
APACHE II score 20 ± 8
SAPS II score 51 ± 20
Length of ICU stay (days) 6 (3 - 11)
ICU mortality (non-survivors) 14
Serum creatinine* (mg/dL) 1.42 ± 0.88
Blood urea nitrogen* (mg/dL) 30 ± 22
Serum uric acid* (mg/dL) 5.2 ± 2.5
Serum phosphate* (mg/dL) 1.12 ± 0.37
Arterial pH* 7.37 ± 0.09
Standard bicarbonate* (mmol/L) 24.8 ± 4.7
Serum anion gap* (mmol/L) 11 ± 3.7
Table 1 Admission reason and patients’ characteristics
(Continued)
Urine anion gap* (mmol/L) 43 ± 42
Creatinine clearance# (mL/min) 66 (33 - 108)
Urine volume# (in 24 h) 1550 (920 - 2720)
Data are means ± standard deviation (SD), median (25th to 75th percentile) or
absolute counts; *At ICU admission; #average of 373 patient days. GI,
gastrointestinal; BMI, body mass index; SOFA, Sequential Organ Failure
Assessment; APACHE II, Acute Physiology and Chronic Evaluation II; SAPS II,
Simplified Acute Physiology Score II; ICU, intensive care unit.
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plasma albumin leading to a neutral arterial pH (Figures 1
and 2). Moreover, these 26 patients were more ventilated
in comparison to the five patients with RTA and acidemia
(pCO2 38 ± 4 vs. 46 ± 5 mmHg; P <0.001) also contribut-
ing to a neutral arterial pH.
Bicarbonate loss was more pronounced in RTA type
II in comparison to RTA type I: RTA type II vs. RTA
type I SBC 23.9 (22.6 to 25.4) vs. 26 (23.9 to 27)
mmol/L; P = 0.004.
Of the 31 patients with RTA 18 presented with transi-
ent RTA and 13 with persistent RTA. The variable tran-
sient vs. persistent RTA was not significantly associated
with the clinical outcomes ‘length of ICU stay’, ‘length of
hospital stay’, ‘ICU survival’ or ‘hospital survival’.
There were no statistical differences between patients
with and without RTA in terms of age, gender, BMI, se-
verity of disease, ICU or hospital outcome, and length of
ICU or hospital stay (Table 2).
Similarly, in the multivariate analysis with RTA as out-
come and diabetes, hypertension, chronic kidney disease,
congestive heart failure, liver cirrhosis, neuroleptic drugs,
muscle relaxants, combined antibiotic schemes, plasma-
pheresis, and sedoanalgesia, as well as age, BMI, gender,
and severity of illness (SAPS II) as co-factors no variables
were predictive for the presence of RTA.
Discussion
Hyperchloremic metabolic acidosis is a frequent entity
in critically ill patients [13]. Therefore, we aimed to
identify the underlying acid-base imbalances with a par-
ticular focus on RTA. As the occurrence of more than
one acid-base disturbance at the same time is common
in critically ill patients [11] our analysis was based on
calculating the base excess subsets according to the
physical-chemical approach by Gilfix et al. [12].
Forty-three percent of the patients presented at least
on one day with hyperchloremic acidosis during the first
week of ICU stay [13]. This is more frequent compared
to Gunnerson et al. who found hyperchloremic acidosis
in only 26% of critically ill patients. However, they did
not determine base excess subsets. Therefore, they could
not detect hyperchloremic acidosis in the state of normal
Figure 1 Daily assessment of the acid-base state during the first 7 days after ICU admission. Forty-three of the patients presented with
hyperchloremic acidosis on one or more days. In 31 patients hyperchloremic acidosis (HCA) was associated with renal-tubular acidosis (RTA)
characterized by a urine osmolal gap (UOG) ≤150 mosmol/kg and a preserved renal function. The majority (23 of 31) of patients with RTA presented
with RTA type II, while 8 of 31 patients showed characteristics of RTA type I. In 26 of the 31 patients with RTA, metabolic acidosis was neutralized
mainly by simultaneously decreased plasma albumin leading to a neutral arterial pH. *On one or more days during the first week after admission;
#glomerular filtration rate (GFR) ≥25 ml/min.
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represented [14].
Hyperchloremic metabolic acidosis was frequently
neutralized by the simultaneous occurrence of metabolic
alkalosis leading to a neutral arterial pH in our patients.
The neutralizing effect is mainly attributed to decreased
plasma albumin levels resulting in a positive base excess
attributable to changes of plasma albumin (BEAlbumin).The ubiquitous occurrence of hypoalbuminemia in crit-
ically ill patients is not seen as counterregulation but is
based on the albumin loss due to third space losses,
plasma dilution or reduced hepatic production (negative
acute phase response) [15-17].
The finding of positive BEAlbumin in a large number of
the included patients is compatible with the study of
Funk et al. [11]. The second neutralizing effect was
Figure 2 Standard base excess (SBE) and base excess subsets
on days with and without renal tubular acidosis. Forty-three
percent of the patients (86 of 373 patient days) presented with
hyperchloremic acidosis on one or more days represented as
pronounced negative BEChloride. However, this was frequently
neutralized mainly by simultaneously decreased plasma albumin
levels resulting in positive BEAlbumin and partly by positive BEUMA
leading to a neutral arterial pH. In 26 of these 43 patients (55 of 373
patient days) hyperchloremic acidosis was associated with RTA
characterized by a UOG of less than 150 mosmol/kg in combination
with a preserved renal function. BEAlbumin, base excess attributable to
changes of plasma albumin; BEChloride, base excess attributable to
changes of plasma chloride; BESodium, base excess attributable to
changes of free water; BEUMA, base excess attributable to unmeasured
anions; RTA, renal tubular acidosis; UOG, urine osmolal gap.
Table 2 Comparison of demographic and outcome
parameters between patients with renal tubular acidosis







Age (years) 63 ± 16 60 ± 17 0.862
Gender (female/male) (28/41) (12/19) 1.000
BMI (kg/m2) 26 ± 5 27 ± 4 0.409
SOFA score on admission 8 ± 4 9 ± 4 0.696
APACHE II score on admission 20 ± 9 19 ± 8 0.224
SAPS II score on admission 51 ± 20 52 ± 20 0.837
Length of ICU stay (days) 5 (3–11) 8 (5–11) 0.157
Length of hospital stay (days) 13 (6–22) 16 (8–33) 0.371
ICU mortality (non-survivors [%]) 16% 10% 0.404
Hospital mortality (non-survivors [%]) 30% 19% 0.332
Deceased within 7 day observation
period
10% 6% 0.717
Data are means ± standard deviation (SD), median (25th to 75th percentile) or
absolute counts. RTA, renal tubular acidosis; BMI, body mass index; SOFA,
Sequential Organ Failure Assessment; APACHE II, Acute Physiology and
Chronic Evaluation II; SAPS II, Simplified Acute Physiology Score II; ICU,
intensive care unit.
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ured anions (BEUMA). The increased BEUMA as seen in
our model of acid-base analysis is in theory either caused
by an increase in unmeasured cations or a decrease in
unmeasured anions. However, our finding of a mildly el-
evated BEUMA in the ‘No RTA’ group is compatible with
the positive BEUMA found in healthy subjects [18].
Therefore, we assume this deviation is caused by a
model artifact and the true normal value of BEUMA is
+1 mmol/L [11]. However, in the ‘RTA’ group BEUMA
was significantly higher in comparison to the ‘No RTA’
group, which can only be explained by the presence of
unmeasured cations in patients with RTA. This
phenomenon has also been seen in the literature and
may be due to the accumulation of guanidines, lithium
intoxications, or paraproteinemias with positively chargedgammaglobulins [19]. Similarly to Mallet et al., the type
and origin of unmeasured cations in the RTA group re-
main open.
To determine the prevalence of RTA we first selected
patients with hyperchloremic acidosis (43 of 100 pa-
tients; Figure 1). Thirty-one of this subgroup presented
with a UOG of less than 150 mosmol/kg in combination
with preserved renal function [5], which is characteristic
for RTA (Figure 1). Thus, our data show for the first
time that RTA was highly prevalent in critically ill pa-
tients with hyperchloremic acidosis, which is suggestive
that RTA contributes to the pathophysiology of hyper-
chloremic acidosis in these patients.
Acidemia (arterial pH <7.35) is associated with un-
favorable outcome in critically ill patients, which may be
pronounced by RTA [14,20]. However, hyperchloremic
acidemia is suggested to be less detrimental than lactic
or ketoacidemia [21]. Moreover, although there is strong
evidence of the association between acidosis and poor
outcome in critically ill patients, there is little evidence
of causation. Mild (hyperchloremic) acidosis may even
be a physiological response as oxygen delivery is en-
hanced via the Bohr effect [22].
In the present trial, RTA in combination with hyper-
chloremic acidosis was not associated with the outcome
parameters lengths of ICU or hospital stay and ICU or
hospital mortality.
Therefore, we hypothesize that RTA in combination
with hyperchloremic acidosis in the present study is not
a harmful condition, but may be a physiological response
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at the same time (Figure 2).
Hyperchloremic acidosis is attributed to several causes.
On the one hand, extrarenal bicarbonate loss may be
based on diarrhea or via surgical drains. This is defined
as a UOG of more than 150 mosmol/kg and was ob-
served in 16% of the patients with hyperchloremic acid-
osis (7 of 43) in the present study (Figure 1). Markedly
decreased renal function (glomerular filtration rate
<25 ml/min [5]) as a potential contributing factor to
metabolic acidosis was seen in 12% (5 of 43) of the pa-
tients with hyperchloremic acidosis (Figure 1).
Parenterally administered solutions with unphysio-
logically high chloride content may contribute to hyper-
chloremic acidosis. This was observed in patients after
rapid isotonic saline infusion while undergoing a surgical
procedure [23]. Although ‘isotonic’ saline was not used
in this study for volume resuscitation, patients may have
received it prior to ICU admission. Furthermore, antibi-
otics and parenteral nutrition contain certain amounts
of chloride. On average the amount of sodium chloride
applied via medication and parenteral nutrition was ra-
ther low and not different between patients with and
without RTA (Table 3).
However, despite the significantly increased blood
chloride levels in patient samples with RTA, urine chlor-
ide levels were not elevated (Table 3). This suggests anTable 3 Comparison of biochemical parameters on days






Arterial pH 7.41 ± 0.07 7.40 ± 0.19 0.421
pCO2 45.3 ± 13.1 39.2 ± 4.9 <0.001
Standard bicarbonate (mmol/L) 27 ± 5 24 ± 2 <0.001
Standard base excess (mmol/L) 3.4 ± 5.1 −0.48 ± 3.51 <0.001
BESodium (mmol/L) 0.0 ± 1.4 0.2 ± 1.2 0.317
BEChloride (mmol/L) −1.4 ± 4.1 −6.9 ± 1.5 <0.001
BEAlbumin (mmol/L) 4.2 ± 1.2 4.2 ± 1.0 0.969
BEUMA (mmol/L) 0.7 ± 2.9 2.3 ± 2.0 <0.001
Serum sodium (mmol/L) 140 ± 5 141 ± 4 0.317
Serum potassium (mmol/L) 4.1 ± 0.5 4.1 ± 0.4 0.894
Serum chloride (mmol/L) 106 ± 5 112 ± 3 <0.001
Serum phosphate (mmol/L) 0.97 ± 0.36 0.89 ± 0.28 0.121
Serum lactate (mmol/L) 1.4 ± 0.9 1.2 ± 0.6 0.319
Urine chloride (mmol/L) 80 ± 42 83 ± 45 0.163
Creatinine clearance (mL/min) 63 (26-106) 83 (46-125) 0.786
NaCl 0.9% infusion per day (mL) 250 (10-550) 300 (114-857) 0.268
Data are means ± standard deviation (SD), median (25th to 75th percentile) or
absolute counts. RTA, renal tubular acidosis; BESodium, base excess attributable
to changes of free water; BEChloride, base excess attributable to changes of
plasma chloride; BEAlbumin, base excess attributable to changes of plasma
albumin; BEUMA, base excess attributable to unmeasured anions.altered renal chloride handling as seen in RTA rather
than external chloride administration.
Hyperchloremia per se is known to cause gastrointes-
tinal symptoms, reduced renal blood flow and glomeru-
lar filtration rate, as well as coagulation disorders [22].
Whereas coagulation disorders and gastrointestinal
symptoms were not studied in the present trial, hyper-
chloremic acidosis per se - independent of the resulting
arterial pH - was not associated with decreased glomeru-
lar filtration rate or with increased length of stay or mor-
tality (data not shown).
Ammonium chloride-loading/frusemide tests and the
bicarbonate-loading test are the golden standards to dis-
tinguish between proximal and distal RTA in non-
critically ill patients [3]. However, due to potential
gastrointestinal, renal, and respiratory side effects of
these drugs we decided to use a non-invasive approach
based on urinary pH and urinary potassium [9].
A potential weakness of our study is the use of the
UOG as a surrogate for urinary ammonium concentra-
tions. However, the direct measurement of urinary am-
monium was not routinely available in our hospital [24].
Another weakness of the present trial is that it was
only a single-center observation with all its known limi-
tations [25].
Moreover, the findings derived from our study are only
associative and are, therefore, naturally only hypothesis
generating.
To compensate for shortcomings in the present trial,
we suggest that future trials should be conducted in a
multicenter setting, should be based on direct measure-
ment of urinary ammonia, should also focus on unmeas-
ured cations, and should prospectively collect data on
multiorgan dysfunction, effectiveness of therapies ad-
ministered, and neurological/cardiac performance.
Hypoalbuminemia is ubiquitous in critically ill patients
represented by positive BEAlbumin. Thus, RTA - in the
presence of normal arterial pH - may be a physiological
response and the result of the counterregulation of
metabolic alkalosis due to low albumin levels.
Conclusions
RTA is highly prevalent in critically ill patients with
hyperchloremic acidosis, whereas it is often neutralized
by the simultaneous occurrence of other acid-base
disturbances.
Key messages
 Hyperchloremic acidosis and renal tubular acidosis
are highly prevalent in critically ill patients
 The simultaneous occurrence of multiple acid-base
disturbances at the same time in the same patient is
common in the critically ill
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